Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa Study To Investigate The Effects of AER 001 on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.

NCT00535028 is registered in ClinicalTrials.gov with Aerovance, Inc. as lead sponsor.

NCT NCT00535028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00535028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa Study To Investigate The Effects of AER 001 on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration.
Lead sponsor
Aerovance, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2005
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma